Skip to main content
logo
Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
77.43
-0.37 (-0.48%)
Aug 5, 2026, 1:12 PM EDT - Market open

Disc Medicine Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-245.89-212.18-109.36-76.43-46.83-35.97
Depreciation & Amortization
0.360.280.160.10.090.03
Stock-Based Compensation
45.4534.3416.825.532.090.51
Other Adjustments
-3.59-6.36-4.770.290.276.61
Changes in Accounts Payable
0.491.07-4.68-3.740.531.32
Changes in Accrued Expenses
8.9211.386.341.951.181.4
Changes in Other Operating Activities
-3.28-8.921.57-1.170.42-1.43
Operating Cash Flow
-197.54-180.39-93.93-73.46-42.25-27.53
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.05-0.93-0.51-0.09-0.15-0.07
Purchases of Investments
-630.2-849.59-386.63---
Proceeds from Sale of Investments
536.83456.2294.8---
Investing Cash Flow
-93.42-394.3-292.33-0.09-0.15-0.07

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--28.99---
Net Long-Term Debt Issued (Repaid)
--28.99---
Issuance of Common Stock
11.52473.41190.72239.3853.720.07
Net Common Stock Issued (Repurchased)
11.52473.41190.72239.3853.720.07
Issuance of Preferred Stock
-----89.86
Net Preferred Stock Issued (Repurchased)
-----89.86
Other Financing Activities
---1.39-95.26-
Financing Cash Flow
262.3473.41218.31239.38148.9889.93

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-28.66-101.29-167.94165.83106.5862.33

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-197.58-181.33-94.43-73.55-42.4-27.6
Free Cash Flow Growth
------
Free Cash Flow Per Share
-5.27-5.14-3.42-3.30-40.79-31.42
Levered Free Cash Flow
-239.45-209.31-77.49-79.37-44.76-34.72
Unlevered Free Cash Flow
-263.01-233.55-127.26-94.19-45.41-29.68
SEC Filings: 10-K · 10-Q